{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:09:03Z","timestamp":1784635743105,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-74779-6","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T12:06:31Z","timestamp":1739793991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["STK11 genetic alterations in metastatic EGFR mutant lung cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Dandan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"6","key":"74779_CR1","doi-asserted-by":"publisher","first-page":"e882","DOI":"10.1002\/ctm2.882","volume":"12","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Genome-wide CRISPR\/Cas9 screening for therapeutic targets in NSCLC carrying wild-type TP53 and receptor tyrosine kinase genes. Clin. Transl. Med. 12(6), e882 (2022).","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"74779_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jtho.2018.10.150","volume":"14","author":"Y Kim","year":"2019","unstructured":"Kim, Y. et al. Concurrent genetic alterations predict the progression to Target Therapy in EGFR-Mutated Advanced NSCLC. J. Thorac. Oncol. 14(2), 193\u2013202 (2019).","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"74779_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jtho.2022.11.022","volume":"18","author":"NJ Choudhury","year":"2023","unstructured":"Choudhury, N. J. et al. Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers. J. Thorac. Oncol. 18(4), 463\u2013475 (2023).","journal-title":"J. Thorac. Oncol."},{"key":"74779_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.lungcan.2017.06.014","volume":"111","author":"C Labb\u00e9","year":"2017","unstructured":"Labb\u00e9, C. et al. Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC). Lung cancer (Amsterdam Netherlands). 111, 23\u201329 (2017).","journal-title":"Lung cancer (Amsterdam Netherlands)"},{"issue":"6","key":"74779_CR5","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00262-023-03370-1","volume":"72","author":"K Morimoto","year":"2023","unstructured":"Morimoto, K. et al. Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer. Cancer Immunol. Immunotherapy: CII. 72 (6), 1699\u20131707 (2023).","journal-title":"Cancer Immunol. Immunotherapy: CII"},{"issue":"9","key":"74779_CR6","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/mc.23750","volume":"63","author":"X Liang","year":"2024","unstructured":"Liang, X. et al. Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer. Mol. Carcinog. 63 (9), 1643\u20131653 (2024).","journal-title":"Mol. Carcinog."},{"issue":"4","key":"74779_CR7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","volume":"23","author":"JM Lizcano","year":"2004","unstructured":"Lizcano, J. M. et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1. EMBO J. 23 (4), 833\u2013843 (2004).","journal-title":"EMBO J."},{"issue":"6","key":"74779_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2004.04.001","volume":"14","author":"AF Baas","year":"2004","unstructured":"Baas, A. F., Smit, L. & Clevers, H. LKB1 tumor suppressor protein: PARtaker in cell polarity. Trends Cell. Biol. 14 (6), 312\u2013319 (2004).","journal-title":"Trends Cell. Biol."},{"issue":"1","key":"74779_CR9","first-page":"e21078","volume":"14","author":"V Sumbly","year":"2022","unstructured":"Sumbly, V. & Landry, I. Unraveling the role of STK11\/LKB1 in non-small cell Lung Cancer. Cureus. 14 (1), e21078 (2022).","journal-title":"Cureus"},{"issue":"10","key":"74779_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ccell.2022.09.010","volume":"40","author":"F Skoulidis","year":"2022","unstructured":"Skoulidis, F., Heymach, J. V. & Cascone, T. A STING operation to expose KRAS and STK11 co-mutated lung cancers. Cancer Cell. 40 (10), 1073\u20131076 (2022).","journal-title":"Cancer Cell."},{"issue":"7400","key":"74779_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon, S. M., Chandel, N. S. & Hay, N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 485 (7400), 661\u2013665 (2012).","journal-title":"Nature"},{"issue":"2","key":"74779_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbadis.2011.09.014","volume":"1822","author":"SB Wu","year":"2012","unstructured":"Wu, S. B. & Wei, Y. H. AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases. Biochim. Biophys. Acta. 1822 (2), 233\u2013247 (2012).","journal-title":"Biochim. Biophys. Acta"},{"issue":"7155","key":"74779_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06030","volume":"448","author":"H Ji","year":"2007","unstructured":"Ji, H. et al. LKB1 modulates lung cancer differentiation and metastasis. Nature. 448 (7155), 807\u2013810 (2007).","journal-title":"Nature"},{"issue":"57","key":"74779_CR14","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1038\/sj.onc.1210594","volume":"26","author":"M Sanchez-Cespedes","year":"2007","unstructured":"Sanchez-Cespedes, M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene. 26 (57), 7825\u20137832 (2007).","journal-title":"Oncogene"},{"issue":"1","key":"74779_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s42003-020-1092-0","volume":"3","author":"P Granado-Martinez","year":"2020","unstructured":"Granado-Martinez, P. et al. STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation. Commun. Biol. 3 (1), 366 (2020).","journal-title":"Commun. Biol."},{"issue":"7","key":"74779_CR16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","volume":"8","author":"F Skoulidis","year":"2018","unstructured":"Skoulidis, F. et al. STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-Mutant Lung Adenocarcinoma. Cancer Discov. 8 (7), 822\u2013835 (2018).","journal-title":"Cancer Discov"},{"issue":"11","key":"74779_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10113129","volume":"10","author":"E Pons-Tostivint","year":"2021","unstructured":"Pons-Tostivint, E., Lugat, A., Fontenau, J. F., Denis, M. G. & Bennouna, J. STK11\/LKB1 modulation of the immune response in lung cancer: from biology to therapeutic impact. Cells 10(11), 1 (2021).","journal-title":"Cells"},{"key":"74779_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejca.2022.05.026","volume":"172","author":"P Rosellini","year":"2022","unstructured":"Rosellini, P. et al. Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer. Eur. J. Cancer. 172, 85\u201395 (2022).","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"74779_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","volume":"185","author":"B Nguyen","year":"2022","unstructured":"Nguyen, B. et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell. 185 (3), 563\u2013575 (2022). e11.","journal-title":"Cell"},{"key":"74779_CR20","doi-asserted-by":"crossref","unstructured":"Liang, X. et al. Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC. J. Cancer Res. Clin. Oncol. (2022).","DOI":"10.1007\/s00432-022-03952-z"},{"issue":"13","key":"74779_CR21","doi-asserted-by":"publisher","first-page":"12265","DOI":"10.1007\/s00432-023-05104-3","volume":"149","author":"X Liang","year":"2023","unstructured":"Liang, X. et al. A clinical decision support system to predict the efficacy for EGFR-TKIs based on artificial neural network. J. Cancer Res. Clin. Oncol. 149 (13), 12265\u201312274 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"18","key":"74779_CR22","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli, G. Y. et al. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics. 32 (18), 2866\u20132868 (2016).","journal-title":"Bioinformatics"},{"issue":"D1","key":"74779_CR23","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"74779_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata, H. et al. KEGG: Kyoto Encyclopedia of genes and genomes. Nucleic Acids Res. 27 (1), 29\u201334 (1999).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"74779_CR25","first-page":"360","volume":"15","author":"E Caiola","year":"2020","unstructured":"Caiola, E. et al. LKB1 Deficiency renders NSCLC cells sensitive to ERK inhibitors. J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer 15(3), 360\u2013370 (2020).","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"6","key":"74779_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/1120009X.2021.2009991","volume":"34","author":"J Sheng","year":"2022","unstructured":"Sheng, J., Liu, L., Dong, T. & Wu, X. Circ_SETD3 regulates gefitinib sensitivity and tumor progression by mir-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer. J. Chemother. 34 (6), 401\u2013413 (2022).","journal-title":"J. Chemother."},{"issue":"6","key":"74779_CR27","doi-asserted-by":"publisher","first-page":"e23037","DOI":"10.1002\/jbt.23037","volume":"36","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. miR-200a-3p promoted cell proliferation and metastasis by downregulating SOX17 in non-small cell lung cancer cells. J. Biochem. Mol. Toxicol. 36 (6), e23037 (2022).","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"74779_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12964-023-01458-w","volume":"22","author":"X Liang","year":"2024","unstructured":"Liang, X., Qin, Y., Wu, D., Wang, Q. & Wu, H. Pyroptosis: a double-edged sword in lung cancer and other respiratory diseases. Cell. Communication Signaling: CCS. 22 (1), 40 (2024).","journal-title":"Cell. Communication Signaling: CCS"},{"key":"74779_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.08.011","volume":"157","author":"A Di Federico","year":"2021","unstructured":"Di Federico, A., De Giglio, A., Parisi, C. & Gelsomino, F. STK11\/LKB1 and KEAP1 mutations in non-small cell lung cancer: prognostic rather than predictive? Eur. J. Cancer. 157, 108\u2013113 (2021).","journal-title":"Eur. J. Cancer"},{"key":"74779_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.lungcan.2017.08.002","volume":"112","author":"F Facchinetti","year":"2017","unstructured":"Facchinetti, F. et al. LKB1\/STK11 mutations in non-small cell lung cancer patients: descriptive analysis and prognostic value. Lung Cancer. 112, 62\u201368 (2017).","journal-title":"Lung Cancer"},{"issue":"4","key":"74779_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell. Biol. 13 (4), 251\u2013262 (2012).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"74779_CR32","unstructured":"Yang, L. et al. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer. Cancer Sci. (2022)."},{"issue":"2","key":"74779_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtho.2020.10.006","volume":"16","author":"X Le","year":"2021","unstructured":"Le, X. et al. Dual EGFR-VEGF pathway inhibition: a promising strategy for patients with EGFR-Mutant NSCLC. J. Thorac. Oncol. 16 (2), 205\u2013215 (2021).","journal-title":"J. Thorac. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74779-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74779-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74779-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T12:06:35Z","timestamp":1739793995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74779-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["74779"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74779-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"6 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was proved by the Ethics Committee of Jiangyin People\u2019s Hospital and performed in accordance with the Declaration of Helsinki. The patient enrolled in this study signed the informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to publication"}}],"article-number":"5729"}}